RXR–LXR heterodimer modulators for the potential treatment of dyslipidemia
摘要:
A number of RXR agonists were synthesized and screened in functional assays. The synthesis and tile structure-activity relationship (SAR) within the series of compounds will be presented. Some in vivo data in rodent models for dyslipidemia and diabetes will also be presented. (c) 2007 Published by Elsevier Ltd.
oxindole synthesis bearing an all-carbon quaternary center, enabled by Pd-catalyzed intramolecular cyclization followed by multiple intermolecular Heck reactions of both easily accessible alkene-tethered carbamoyl chlorides and olefins. This protocol obviates the use of prefunctionalized olefinic reagents, exhibits excellent functional group tolerance, and features fascinating reactive versatility.
Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
申请人:Lagu Bharat
公开号:US20070078129A1
公开(公告)日:2007-04-05
The present invention relates to compounds of Formula (I),
methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.
申请人:SHELL INTERNATIONALE RESEARCH
MAATSCHAPPIJ B.V.
公开号:EP0212726A2
公开(公告)日:1987-03-04
The growth of unwanted plants is controlled by certain optionally substituted cinnoline-4-carboxylic acids and ester, amino, hydroxamic acid and hydrazide derivatives thereof, and salts and N-oxides of such compounds, The invention further includes compositions containing such compounds, the preparation of the compounds and compositions, and certain novel compounds per se.